Brookstone Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-776
| Closed | -$254K | – | 1070 |
|
|
2024
Q4 | $254K | Sell |
776
-25
| -3% | -$7.87K | ﹤0.01% | 873 |
|
|
2024
Q3 | $240K | Sell |
801
-32
| -4% | -$9.8K | ﹤0.01% | 905 |
|
|
2024
Q2 | $272K | Buy |
833
+23
| +3% | +$8.13K | ﹤0.01% | 817 |
|
|
2024
Q1 | $321K | Sell |
810
-4,131
| -84% | -$1.53M | 0.01% | 739 |
|
|
2023
Q4 | $1.74M | Sell |
4,941
-1,914
| -28% | -$677K | 0.03% | 353 |
|
|
2023
Q3 | $2.53M | Sell |
6,855
-34
| -0.5% | -$13.1K | 0.06% | 270 |
|
|
2023
Q2 | $2.56M | Buy |
6,889
+16
| +0.2% | +$5.72K | 0.05% | 274 |
|
|
2023
Q1 | $2.49M | Sell |
6,873
-251
| -4% | -$73.3K | 0.05% | 288 |
|
|
2022
Q4 | $1.66M | Buy |
7,124
+34
| +0.5% | +$8.06K | 0.03% | 339 |
|
|
2022
Q3 | $1.7M | Sell |
7,090
-45
| -0.6% | -$13.7K | 0.04% | 309 |
|
|
2022
Q2 | $2.27M | Sell |
7,135
-50
| -0.7% | -$16.3K | 0.05% | 268 |
|
|
2022
Q1 | $2.86M | Sell |
7,185
-1,114
| -13% | -$436K | 0.06% | 244 |
|
|
2021
Q4 | $3.24M | Buy |
8,299
+7,117
| +602% | +$3.06M | 0.06% | 210 |
|
|
2021
Q3 | $476K | Buy |
+1,182
| New | +$498K | 0.01% | 510 |
|
|
2020
Q1 | – | Sell |
-1,455
| Closed | -$219K | – | 437 |
|
|
2019
Q4 | $219K | Sell |
1,455
-1,110
| -43% | -$162K | 0.01% | 380 |
|
|
2019
Q3 | $364K | Sell |
2,565
-1,106
| -30% | -$152K | 0.02% | 312 |
|
|
2019
Q2 | $459K | Sell |
3,671
-1,102
| -23% | -$130K | 0.03% | 285 |
|
|
2019
Q1 | $526K | Buy |
+4,773
| New | +$496K | 0.03% | 209 |
|
|
2018
Q4 | – | Sell |
-4,620
| Closed | -$570K | – | 406 |
|
|
2018
Q3 | $570K | Sell |
4,620
-1,218
| -21% | -$137K | 0.04% | 228 |
|
|
2018
Q2 | $580K | Buy |
+5,838
| New | +$537K | 0.05% | 185 |
|
Other funds holding WST
DCP
